ABSTRACT-The effects of lacidipine (LC), a new dihydropyridine calcium antagonist, were studied in comparison with those of nifedipine (NF) in isolated arteries of the dog (DG-AR) and isolated aorta (GP AO), left and right atria (GP-LA, GP-RA) and ventricular papillary muscles (GP-PM) of the guinea pig. In DG-AR precontracted with high K+, LC and NF produced a concentration-dependent relaxation. The relax ant effect of LC was most potent in the basilar artery. The calcium antagonistic effects of LC was 8.7 and 2.1 times more potent than those of NF, in GP-AO and GP-LA, respectively. Thus, LC was about 4 times more selective towards vascular smooth muscles than NF. The negative chronotropic effects in GP-RA and the negative inotropic effect in GP-PM of NF were more pronounced than those of LC. NF was more potent in inhibiting the action potential of GP-PM than LC both in normal polarized and depolarized conditions. The effects of LC were long-lasting. These results suggest that LC is a potent, highly vascular-selective calcium antagonist with little cardiodepressant effects and as such may be suitable for the treatment of hypertension.
(Glaxo, Berona, Italy), is a new di hydropyridine calcium antagonist with the chemical struc ture shown in Fig. 1 , in which the 3,5 methylester in the di hydropyridine ring and NO2 in position 1 of the benzene ring of nifedipine were substituted with ethylesters and a long chain 3-(1,1-dimethylethoxy)3-oxo-l-propenyl, respectively. The presence of a long chain is unique among the dihydropyridine calcium antagonists. In sev eral smooth muscles preparations (1, 2) , lacidipine was shown to produce a long-lasting calcium antagonistic effect. In the present study, calcium antagonistic effects of lacidipine were studied in the isolated dog arteries, isolat ed aorta, right and left atria and papillary muscles of the guinea pig in comparison with those of nifedipine to as sess the organ selectivity and the cardiodepressent effects. 
MATERIALS AND METHODS

Isolated canine arteries preparation
The mongrel dogs of either sex (9-17 kg) were anesthe tized with thiopentobarbital (35 mg/kg, i.v.) and exsan guinated from the common carotid arteries. The basilar, coronary (large: main left circumflex artery; small: small branch of the anterior descending artery), mesenteric, renal and femoral arteries were isolated and cleaned free of excess tissues. Endothelium was removed by rubbing the luminal surface with a stainless bar. Each artery was cut into rings (2 to 3-mm-wide) and mounted in a 10-ml organ bath for recording the isometric contractions. The preparations were equilibrated at a resting tension of 0.5-2.5 g (basilar: 0.5 g, coronary-large: 1.0 g, coronary small: 0.5 g, mesenteric: 1.0 g and femoral: 2.5 g). The bathing solution was Tris buffer (Tris) containing: 125 mM NaCl, 2.7 mM KCI, 2.0 mM CaC12, 1.2 mM MgC12, 11.0 mM glucose and 23.8 mM Trizma base (pH was ad justed to 7.4 at room temperature). It was continuously bubbled with 02 gas at 35 ± 0.1 C . The isometric contrac tion was measured by a force-displacement transducer (Toyo Baldwin T7-30-240, Tokyo) connected to a strain amplifier (Sanei 6M81, Tokyo) and recorded on a servo corder (Graphtec SR6211, Tokyo). After confirmation of the reproducibility of contraction by 60 mM K+ Tris (high K+) during the 3 -4 hr of the equilibration period, three doses of lacidipine and nifedipine were administered to the preparations at 2-hr intervals. The preparations were recontracted with high K+. Isosmotic high K+ was prepared by replacing NaCI with equimolar K2SO4.
Isolated aorta, left and right atria and papillary muscle preparations of the guinea pig Male albino guinea pigs (250 450 g) were anesthetized with ether. The heart and thoracic aorta were quickly ex cised and cleaned free of excess tissues. The following three types of experiments were performed.
Calcium antagonistic action in the isolated aorta: The isolated aorta was cut into 2 to 3-mm-wide rings and was mounted in an organ bath for recording of the isometric contractions under a 1.0-g resting tension. The pro cedures used were as described above for the canine ar teries. After confirmation of the reproducibility of con traction by 60 mM K+ Tris (high K+) during an accom modation period, the preparations were incubated with ethanol (solvent of the calcium antagonists) or calcium antagonists for 2.5 hr. Then, the preparations were incu bated for 30 min in Ca2+-free high K+ medium with the drug. The preparations were washed with Ca2+-free high K+ Tris (including the drug). CaC12 was added to the bath cumulatively. The contraction produced by the last ad ministration of high K+ was taken as 100 010, and the con tractions induced by a cumulative application of CaC12 were expressed as a 010 of this value, and the pA2 values were calculated by the following equation:
where A is the concentration of Ca 2+ at which 50010 of the maximum contraction was obtained without calcium an tagonists, A' is the concentration of Ca 2+ at which 50010 of the maximum contraction was obtained in the presence of calcium antagonists, and B is the concentration of cal cium antagonists. Isoosmotic high K+ solution was pre pared by replacing NaCI with equimolar KC1.
Calcium antagonistic action in the left atria: The proce dure described by Pappano (3) was used. The atria were divided carefully into the right and left halves. The left atria were mounted in organ baths under a resting tension of 0.2-0.3 g. The bathing solution was Tyrode's solution (Tyrode) of the following composition: 137 mM NaCl, 2.7 mM KC1, 1.9 mM CaC12, 1 .0 MM MgC12, 11.9 MM NaHCO3, 0.4 mM NaH2PO4 and 5.5 mM glucose; it was continuously bubbled with 95010 02+5% CO2 at a temper ature of 35 ±0.1 C . The preparation was stimulated elec trically at a frequency of 1 Hz with a square wave pulse of 1-msec duration and of a voltage approximately 30010 above the threshold supplied by a square-wave stimulator (Nihon Kohden MSE-3, Tokyo) via a pair of silver plate electrodes between which the preparations were placed. The isometric contraction was recorded on a linearly recording thermostylus oscillograph (Watanabe WTR 281, Tokyo) with a force-displacement transducer cou pled with a carrier-amplifier (Sanei N6882). After a 1-hr equilibration period in Tyrode, the bathing solution was switched to the high K+ (22.0 mM) Tyrode (high K Tyrode), and the stimulation frequency was reduced to 0.4 Hz (duration 5 msec). Under this condition, the preparation was depolarized, and the contraction disappeared in less than 2 or 3 min. After a further equilibration period of 45 min, 2 x 10-' M isoproterenol (ISP) was added to the bathing solution. Contractile activities resumed in as sociation with the appearance of calcium-dependent ac tion potential. Ten minutes after ISP administration, the concentration of Ca 21 in the high K+ bathing solution was reduced to 0.6 mM, and the dependency of contrac tile tension on the Ca 21 concentration was examined by cumulatively increasing the concentrations of CaC12. Then the preparations were incubated either with ethanol or with lacidipine or nifedipine for 40 min, and the de pendency of the contraction on Ca 21 was examined again by constructing another cumulative dose-response curve for CaC12, from which the pA2 values were calculated.
Chronotropic and inotropic effects in guinea pig right atria and papillary muscles: The right atria and right ven tricular papillary muscles were mounted in organ baths under resting tensions of 0.25 g and 0.1 g, respectively. The bathing solution was a Krebs-Henseleit solution (Krebs-Henseleit) containing: 118 mM NaCl, 4.7 mM KC1, 2.5 mM CaC12, 1.2 MM MgSO4, 25.0 mM NaHCO3, 1.2 mM KH2PO4 and 12.0 mM glucose; the solution was continuously bubbled with 95 % 02 + 5 % CO2 and kept at a temperature of 35±0.1'C.
The right atria, which retained spontaneous rhythm, was used to assess the chronotropic action of the calcium antagonists. The rate of the spontaneous contraction (heart rate) was recorded on a linearly recording thermostylus oscillograph with a force-displacement transducer and a carrier-amplifier. The papillary muscles were stimulated using the proce dures as described for the left atria with a voltage approxi mately 20010 above the threshold. All preparations were al lowed to equilibrate for 1 hr. Changes in heart rate and contractile tension produced by lacidipine and nifedipine were recorded for 40 min.
Effects on the action potential of right ventricularpapil lary muscles: The papillary muscle was mounted in a 1-ml perfusion chamber and continuously superfused at a flow rate of 9 ml/min with a Krebs-Henseleit bubbled with 95 010 02 + 5 % CO2 and kept at a temperature of 3 51C. The preparation was stimulated electrically by a square wave pulse of 0.2-msec duration at a frequency of 0.5 Hz with a voltage of 4-5 times the threshold supplied by a square wave pulse stimulator (Nihon Kohden SEN-6100). Trans membrane potentials were recorded with a glass capillary micro-electrode filled with 3 M KCl with an electrical resistance of 10-30 MQ. The action potentials were dis played on a cathode-ray oscilloscope (Nihon Kohden VC7) and photographed by a long-recording camera (Nihon Kohden RCL-6101). The following electrophysio logical parameters were evaluated: the maximal rate of upstroke of the action potential (V,,,a,), action potential amplitude (APA), action potential duration at 50° repo larization (APD50) and action potential duration at 90% repolarization (APD90). After recording the normal action potentials, the bath ing solution was switched to high K+ (25 mM) Krebs-Hen seleit, and calcium-dependent action potentials were in duced by addition of ISP (10-6 M). Calcium antagonists were applied and changes in action potentials were record ed for 15-20 min. The concentration of the drug was changed at intervals of 40 min.
The animals were treated in accordance with the estab lished rules for Animal Experiments of this University.
Drugs
Lacidipine (Glaxo) and nifedipine (Sigma, St. Louis, MO, USA) were dissolved in ethanol and diluted with distilled water. L-Isoproterenol hydrochloride (Nikken Kagaku, Tokyo) was dissolved in distilled water. Throughout the experiment, calcium antagonists were protected from light.
Statistical analyses
All values are presented as the mean ±S.E. To evaluate the differences between the means, Student's t-test was conducted, and a probability value of less than 0.05 was considered to be significant. ter 30 min. However, the same incubation time was used even with nifedipine. As it was found that the contraction by 60 mM K2SO4 was stable at least for 6 hr, three doses of calcium antagonists were administered successively in a cumulative manner. Dose-dependent relaxations were produced by lacidi pine and nifedipine. The concentrations necessary for elicitation of 50% relaxation (IC50) are listed in Table 1 . The effect of lacidipine was the most potent in the basilar artery with an IC50 of 0.41 nM, which was significantly lower than the IC50 of nifedipine in the same artery (i.e.,
1.64 nM). The rank order of potency of lacidipine was: basilar > coronary > renal > mesenteric > femoral, and that of nifedipine was: basilar > coronary > renal > mesenteric > femoral, although the potencies in these arteries were somewhat similar to each other except for that of nifedi pine in the femoral artery (IC50: 8.52). There were no differences in the relaxant effects of these two agents on the large and small coronary artery. Table 2 . pA2 values of lacidipine and nifedipine (n=5 14)
Fig Isolated aorta, left and right artia and papillary muscle preparations of the guinea pig Calcium antagonistic effects in the guinea pig aorta: In a preliminary study, it was found that the contraction by CaC12 became smaller 2, 3 or 5 hr after the start of the experiment. We, therefore, carried out the control-runs (ethanol-pretreatment) simultaneously with the drug pretreated runs. As the degree of inhibition of Ca2+ con traction induced by lacidipine at an incubation time of 3 hr was found to be almost the same as that obtained at an incubation time of 5 hr, the time of incubation with lacidi pine was set at 3 hr. Figure 3 depicts the cumulative concentration-response curves for contractions induced in high K depolarizing so lution by CaC12, and the effects of lacidipine and nifedi pine thereupon. The concentrations of these calcium an tagonists that caused a rightward shift by about one order without significantly depressing the maximum responses were chosen. Lacidipine (3 x 10-10 M) and nifedipine (3 x 10-9 M) caused a shift to the right of the cumulative concentration-response curves for CaC12. The apparent pA2 values for lacidipine and nifedipine were 10.19 and 9.25, respectively (Table 2) . Thus, judging from the pA2 values, lacidipine was 8.7 times more potent as calcium an tagonist than nifedipine in the guinea pig aorta. Calcium antagonistic effects in guinea pig left atria: Figure 4 depicts the cumulative concentration-response curves for contractions induced by CaC12 in high K+ depolarizing solution and the effects of lacidipine and nifedipine thereupon. Lacidipine (3 x 10-8 M) and nifedi pine (10-7 M) caused a shift to the right of the cumulative concentration-response curves for CaC12. The pA2 values for lacidipine and nifedipine were 7.35 and 7.02, respec tively (Table 2 ). Thus, lacidipine was 2.1 times more po tent as a calcium antagonist than nifedipine in the guinea pig left atria.
Chronotropic and inotropic effects in guinea pig right atria and papillary muscles: Table 3 summarizes the effects of lacidipine and nifedipine on the rate of beating of the right atria and the contractile tension of the papil lary muscles. The rate of beating and the contractile tension before administration of drugs were 179±5 beats/min (n=5) and 0.53±0.14g (n=5) in the lacidipine group and 163--t4 beats/min (n=6) and 0.48±0.11 g (n=4) in the nifedipine group. There were no significant differences between these values. The negative chronotropic and in otropic effects of lacidipine were slight even at the maxi mum concentration that can be used: The rate of beating and the contractile tension were 87010 and 5607o of the values just before administration of the drug, respective ly. The same dose of nifedipine induced cardiac arrest and a severe negative inotropic effect, the contractile ten sion becoming 8% of the value just before administration of the drug. Table 3 .
Effects of 10-6 M lacidipine and nifedipine on heart rate, contraction and action potentials in normal Krebs-Henseleit solution Electrophysiological effects in guinea pig papillary mus cles: Table 3 summarizes the effects of 10-6 M lacidipine and nifedipine on the Vm, APA, APD50 and APD90 of the action potentials of the guinea pig papillary muscles. The Vmax, APA, APD50 and APD90 before administration of the drugs were 180±4 V/sec, 123±0.4 mV, 156±1 and 187 ± 2 msec (n=6), in the lacidipine group (n=6) and 176±2 V/sec, 123±0.4 mV, 155±2 and 188±2 msec (n = 6), in the nifedipine group. There were no significant differences between the respective parameters of the two groups. The onset of action of lacidipine and nifedipine was slow, the effects stabilizing only after 40 min with lacidipine and after 20 min with nifedipine. Lacidipine and nifedipine did not modify Vma, and APA, but sig nificantly decreased APD50 and APD90. The reduction in APD50 and APD90 produced by lacidipine was slight, while the effects produced by nifedipine were remarkable. Figure 5 depicts the effects of 10-7-10-6 M of lacidi pine and nifedipine on Vm, APA, APD50 and APD90 of the calcium-dependent action potentials. The Vm, APA, APD50 and APD90 before administration of drugs were 30±1 V/sec (n=8), 86±1 mV (n=9), 126±3 (n=9) and 141 ± 3 msec (n = 8) in the lacidipine group (n = 6) and 32±1 V/sec (n=6), 89±1 mV (n=6), 122±2 (n=6) and 133±3 msec (n=6) in the nifedipine group. There were no significant differences between the respective param eters of the two groups. Lacidipine produced a dose-de pendent and significant decrease in V. a.,, APA, APD50 and APD90. They became 58, 89, 78 and 80%, respective ly, of the control after 10-6 M lacidipine. Depressant effects on action potentials were more marked with nifedipine than with lacidipine. Vm, APA, APD50 and APD90 became 43, 96, 74 and 77%, respectively, of the control after 10-' M nifedipine. After 10-6 M nifedipine, the papillary muscles no longer responded to electric stimuli.
DISCUSSION
According to a study conducted in the rabbit ear artery, the calcium-antagonistic effect of lacidipine was a little less marked but longer-lasting than that of nitrendipine (1, 2) . In the same report, the relaxation of the rat aorta, colon and bladder and guinea pig trachea was observed with lacidipine. In the present study, we attempted to fur ther clarify the pharmacological effects of lacidipine using the isolated canine arteries and the isolated aorta, left and right atria, and papillary muscle of the guinea pig. The potencies of actions of lacidipine in various arteries, differ ences of calcium-antagonistic effects between the vascular and cardiac tissues and the effects on the electrophysiologi cal parameters were compared with those of nifedipine.
Both lacidipine and nifedipine relaxed various arteries. The rank order of potency of lacidipine was: basilar > coronary > renal > mesenteric > femoral. The IC50 of lacidipine was the lowest in the basilar artery. The value was significantly lower than that of nifedipine in the same artery. The relaxation by nifedipine was much the same among several arteries except that the relaxant effect was weak in the femoral artery. The rank order of potency of nifedipine was similar to that reported by Shimizu et al.
(4).
The calcium antagonistic effects of lacidipine and nifedi pine were found to be about 690 and 180 times more po tent in the aorta than in the atria in the present study. This finding is in agreement with the general belief (5 7) that as compared with the effects of the non-dihydro pyridine calcium antagonists such as verapamil and dil tiazem, the effects of dihydropyridine calcium antagonists as represented by nifedipine are more potent in vascular tissue than in cardiac tissue. According to Nakayama and Kasuya (8) , the dose ratio of flunarizine, a calcium an tagonist with a high selectivity towards vascular tissue, for inhibition of K+-contracture of the basilar artery and for inhibition of the isometric contraction of the papillary muscle was 1:625. Thus, the vascular selectivity of lacidi pine was even greater than that of flunarizine. The degree of vascular selectivity varied among dihydropyridine cal cium antagonists. For instance, the selectivity towards the vascular systems was about 4 times more potent with lacidipine than with nifedipine because the calcium an tagonistic effects of lacidipine were 8.7 and 2.1 times more potent than those of nifedipine in the aorta and the atria, respectively. This vascular selectivity of lacidipine is equal to that of nitrendipine (2), but is lower than that of nicardipine which is about 16 times more selective than that of nifedipine (7). The inhibition of the rate of beating of atria and the in hibition of contraction of papillary muscles of the guinea pig was less than 5010 with 10-6 M lacidipine, the maxi mum concentration that can be used in the present study, indicating that the inhibitory effect of lacidipine on the normal cardiac muscles was very weak. Similar results were reported by Cerbai et al. in sheep Purkinje fiber (9) . In contrast, 10-6 M nifedipine produced an arrest in the right atria and inhibited the contraction of papillary mus cles more than 90%.
In the guinea pig papillary muscles, lacidipine and nifedipine did not produce a significant inhibition of the normal action potential except for a significant shortening of APD50 and APD90 produced by nifedipine. Lacidipine significantly and concentration-dependently inhibited Vmax, APA, APD50 and APD90 of the calcium-dependent action potential This is in harmony with the findings of Cerbai et al. (9) and Nabata (10) that the inhibitory effects of lacidipine and nifedipine on the action potential were more potent in depolarized muscle than in normally pola rized muscle. The inhibition by lacidipine was about 10 times less potent than that of nifedipine (the inhibition by 10-6 M lacidipine was equal to that of 10' M nifedi pine).
It is well known that dihydropyridine calcium an tagonists block L-type calcium channels which are widely distributed in tissues, particularly in the heart and smooth muscle (11) . Though the vascular selectivity of dihy dropyridine calcium antagonists is obvious (5 7), the mechanisms by which this selectivity is brought about is not clear at present. According to a hypothesis, the vascu lar selectivity is due to the participation of the high affin ity binding site in the inhibitory effect on the calcium chan nels of vascular tissues. In contrast, the inhibitory effect in intact myocardial cell is mediated through a low affinity site (12) . Another hypothesis explains the selectivity on the basis of selective binding of dihydropyridine calcium antagonists to calcium channels under the depolarization condition (13) . The inhibitory effects are stronger in vascu lar tissue because vascular smooth muscle has a more depolarized resting membrane potential than cardiac mus cles; potentials are in the range of -30 to -40 mV (14) . The fact that the effects of nitrendipine are potentiated in the depolarized state because of a significant increase in high affinity binding sites (15, 16 ) is consistent with the second hypothesis. The finding of the present study that the cardiac action of lacidipine was potentiated when the preparations were exposed to a depolarizing solution is also in line with the second hypothesis. The selectivity of lacidipine found in the present study may also be explained by the fact that the resting potential of the cerebral microvessels is much lower than that of the peripheral vessels (17) .
The vascular selectivity of dihydropyridine calcium an tagonists (18) was found to increase as the lipophilicity of the compound increases. Thus, the higher lipophilicity may be another factor contributing to the higher vascular selectivity of lacidipine, a compound with a long chain in position 1 of the benzene ring.
There are different isoforms of the L-type channels (19) . McKenna et al. (20) suggested the existence of a sub tle modification in the structure of the calcium channels. However, our present knowledge is insufficient to decide whether the presence of isoforms can explain the differ ences among tissues. Further experiments are needed to clarify the mechanisms underlying the vascular selectivity of Ca 2+ antagonists of the dihydropyridine type.
In vitro experiments conducted with rabbit ear and basi lar artery (1, 2) have shown that the action of lacidipine is long-lasting. In in vivo experiments with conscious animals and experimental hypertensive animals (spontane ously hypertensive rats, salt-loaded Dahl-S rats and renal hypertensive dogs), the onset of the blood pressure lower ing effect of lacidipine was very slow and the duration was long (1, 2, 21, 22); Lacidipine administered orally in con scious spontaneously hypertensive rats proved to be about 8 times slower in onset and about 4 times longer lasting than nitrendipine and nicardipine (2, 23) . Our study confirmed the long-action of lacidipine. As just mentioned, lacidipine has a long chain in the position 1 of the benzene ring and has a oil/water partition coefficient of 14400 (M. Ogawa et al., Glaxo Japan, Tsukuba, per sonal communication), a value about 10 times higher than that of nifedipine, which was 1387 (24). Gaviraghi (25) and Godfraind and Salomone (26) presented a three compartment model to explain the long duration of ac tion. The model postulates a compartment with a lipid binding site (designated as the "proximate lipid") that is in contact with an aqueous compartment. As lacidipine is highly lipophilic, it would concentrate in this compart ment to be continuously released into an aqueous com partment during the washout period. The aqueous com partment in turn delivers lacidipine to another compart ment in which binding to protein (receptor) occurs.
The results obtained in the present study suggest that lacidipine is a potent, long-lasting calcium antagonist with a high vascular-selectivity and a weak cardiodepres sant action and as such may be particularly suited for treatment of hypertension.
